Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

KuibyshevAzot reported for 3 months of 2024 by RAS

4/27/24 KAZT

Ashinsky Metzavod reported for 2023 by IFRS

4/27/24 AMEZ

CZPSN reported for 2023 by RAS

4/27/24 PRFN

Belon reported for 2023 by IFRS

4/27/24 BLNG

Rosseti Kuban reported for 3 months of 2024 by RAS

4/27/24 KUBE

PhosAgro reports for 3 months of 2024 by RAS

4/26/24 PHOR

Phosagro reports for 2023 by IFRS

4/26/24 PHOR

TNS Energy Mari El reported for 3 months of 2024 by RAS

4/26/24 MISB

O'Key's Q1 revenue grew by 7.2%

4/26/24 OKEY

Board of Directors of Kuznetskiy Bank recommended that dividends be paid for 2023

4/26/24 KUZB